We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

PBLA Panbela Therapeutics Inc

0.04 (3.12%)
Last Updated: 14:36:41
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 11,292
Bid Price 1.30
Ask Price 1.36
News -
Day High 1.33


52 Week Range


Day Low 1.30
Company Name Stock Ticker Symbol Market Type
Panbela Therapeutics Inc PBLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 3.12% 1.32 14:36:41
Open Price Low Price High Price Close Price Prev Close
1.32 1.30 1.33 1.28
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
185 11,292 $ 1.31 $ 14,802 - 1.21 - 453.60
Last Trade Time Type Quantity Stock Price Currency
14:53:11 1 $ 1.33 USD

Panbela Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.9M 2.96M - 0 -34.93M -11.81 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Panbela Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PBLA Message Board. Create One! See More Posts on PBLA Message Board See More Message Board Posts

Historical PBLA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.331.371.211.2726,032-0.01-0.75%
1 Month1.351.541.211.4274,190-0.03-2.22%
3 Months2.,527-0.87-39.73%
6 Months15.25223.851.2111.641,762,820-13.93-91.35%
1 Year435.00453.601.2187.163,276,070-433.68-99.7%
3 Years4,080.0010,560.001.21290.371,270,960-4,078.68-99.97%
5 Years4,080.0010,560.001.21290.371,270,960-4,078.68-99.97%

Panbela Therapeutics Description

Panbela Therapeutics Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for the second indication in chronic pancreatitis. The firm has developed a polyamine analogue compound referred as SBP-101 for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications.
Your Recent History
Panbela Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230927 19:08:52